Correlation Between Atresmedia Corporacin and Oryzon Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Atresmedia Corporacin and Oryzon Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atresmedia Corporacin and Oryzon Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atresmedia Corporacin de and Oryzon Genomics SA, you can compare the effects of market volatilities on Atresmedia Corporacin and Oryzon Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atresmedia Corporacin with a short position of Oryzon Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atresmedia Corporacin and Oryzon Genomics.

Diversification Opportunities for Atresmedia Corporacin and Oryzon Genomics

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Atresmedia and Oryzon is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Atresmedia Corporacin de and Oryzon Genomics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oryzon Genomics SA and Atresmedia Corporacin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atresmedia Corporacin de are associated (or correlated) with Oryzon Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oryzon Genomics SA has no effect on the direction of Atresmedia Corporacin i.e., Atresmedia Corporacin and Oryzon Genomics go up and down completely randomly.

Pair Corralation between Atresmedia Corporacin and Oryzon Genomics

Assuming the 90 days trading horizon Atresmedia Corporacin de is expected to generate 0.59 times more return on investment than Oryzon Genomics. However, Atresmedia Corporacin de is 1.71 times less risky than Oryzon Genomics. It trades about -0.06 of its potential returns per unit of risk. Oryzon Genomics SA is currently generating about -0.06 per unit of risk. If you would invest  457.00  in Atresmedia Corporacin de on October 9, 2024 and sell it today you would lose (9.00) from holding Atresmedia Corporacin de or give up 1.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Atresmedia Corporacin de  vs.  Oryzon Genomics SA

 Performance 
       Timeline  
Atresmedia Corporacin 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Atresmedia Corporacin de has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Atresmedia Corporacin is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Oryzon Genomics SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oryzon Genomics SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Atresmedia Corporacin and Oryzon Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Atresmedia Corporacin and Oryzon Genomics

The main advantage of trading using opposite Atresmedia Corporacin and Oryzon Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atresmedia Corporacin position performs unexpectedly, Oryzon Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oryzon Genomics will offset losses from the drop in Oryzon Genomics' long position.
The idea behind Atresmedia Corporacin de and Oryzon Genomics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Directory
Find actively traded commodities issued by global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Stocks Directory
Find actively traded stocks across global markets